ABRAHAM KATZ: Open Payments
NPI 1538279807 · EL PASO, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,423 in 140 payments from 9 companies in 2025. Trend: 2023 $1,538 · 2024 $2,195 · 2025 $2,423
Food & beverage: $2,312Education: $111
| Company | Payments | Amount |
|---|---|---|
| Corium, LLC | 21 | $531 |
| Alkermes, Inc. | 15 | $383 |
| Lundbeck LLC | 25 | $346 |
| Vanda Pharmaceuticals Inc. | 17 | $289 |
| Otsuka America Pharmaceutical, Inc. | 29 | $284 |
| Axsome Therapeutics, Inc. | 8 | $196 |
| Teva Pharmaceuticals USA, Inc. | 8 | $169 |
| ABBVIE INC. | 15 | $169 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $56 |
Products named: REXULTI, Azstarys, ARISTADA, FANAPT, VRAYLAR, Sunosi, LYBALVI, Auvelity.
Industry payments across TX — which companies pay providers there.
